Parkway Cardiology associates

Oak Ridge, Tennessee 37830

2 studies enrolling now · 8 studies all time

What they study most

ASCVD, Cardiovascular Disease, Coronary Heart Disease (CHD), Coronary Revascularization, Genetics of Drug Metabolism, Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Myocardial Infarction, Obesity, Stroke, Vascular Disease

Studies at this site

• OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction — Running, not enrolling
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes — Completed
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early
• Diagnosing Adverse Drug Reactions Registry — Status unconfirmed